Research

Clair Health launches US$1m fund to support women’s health research

By Published On: November 18, 2026
Clair Health launches US$1m fund to support women’s health research

Clair Health has launched a US$1m research fund to support studies aimed at addressing longstanding gaps in women’s health knowledge.

The Clair Research Fund will distribute funding across multiple cohorts over the next five years, beginning with a fellowship programme supporting up to 10 early-career researchers.

Each fellow will receive up to US$15,000 in funding, Clair monitoring devices and access to research data collected by the company.

The programme will also cover travel costs for researchers to present their findings at a scientific conference.

“Clair is on a mission to bridge the data gap in women’s health,” said Abhinav Agarwal, co-founder and chief technology officer of Clair.

“We can’t do that alone. The field moves forward when people with different backgrounds and expertise work on it, so we’re funding researchers to ask their own questions with Clair.”

The initiative aims to address the chronic underfunding of women’s health research, which has left significant gaps in understanding female-specific conditions and health needs.

Women were not required to be included in National Institutes of Health-funded research in the US until 1993. Research from McKinsey has also found that just 1% of healthcare research and innovation funding goes towards female-specific conditions beyond oncology.

These gaps are reflected in areas including menopause and reproductive health. Only 7% of obstetricians and gynaecologists report feeling adequately prepared to provide menopause care as a result of their medical education.

Polycystic ovary syndrome (PCOS), which affects around one in eight women, takes an average of seven years to diagnose, with approximately 70 per cent of affected women remaining undiagnosed.

The first fellowship cohort will be able to investigate topics across five research areas: menstrual cycle physiology in everyday life; perimenopause and menopause; women in sport and training; medications and hormone exposures; and symptoms, mood and sleep.

An open category will also accept proposals exploring other areas of women’s health.

Clair said its continuous hormone monitoring technology collects physiological data that could help researchers investigate questions that have previously lacked sufficient evidence.

Meela Ghani, reproductive endocrinology PhD and research scientist at Clair, said: “The best research questions come from people close to the problem.

“We’re giving fellows the tools to ask those questions and the support to answer them well.”

The fellowship is open to US-based early-career researchers, including graduate students, postdoctoral researchers, medical residents and fellows, junior faculty and independent researchers.

Applications close on 15 January 2027, with successful applicants due to be notified by 1 February.

Clair is also inviting other women’s health and health technology companies to contribute devices to the programme, which will be matched with researchers whose projects align with their products.

Further information and application details are available at http://wearclair.com/research/fellowship.

Review finds no evidence that testosterone improves brain fog during menopause
Post